Quanterix Corp (NAS:QTRX)
$ 12.33 -0.14 (-1.12%) Market Cap: 473.21 Mil Enterprise Value: 215.93 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 70/100

Quanterix Corp at Canaccord Genuity Growth Conference Transcript

Aug 07, 2019 / 01:30PM GMT
Release Date Price: $28.59 (-1.55%)
Mark Anthony Massaro
Canaccord Genuity Corp., Research Division - Senior Analyst

All right. We're going to get started. My name is Mark Massaro. I'm the lead diagnostics and tools analyst at Canaccord. Pleased to welcome you to the 39th Annual Growth Conference here. I'm really excited to host Quanterix for the second consecutive year. I've got Chairman, President and CEO, Kevin Hrusovsky, and we have Stephen Hrusovsky, in the back of the room.

For those of you unfamiliar, Quanterix is a fast-growing precision medicine company. It's really doing some amazing work, in particular in the field of neurology and many other fields, and increasingly, it's moving into oncology.

Kevin, thank you very much for being here.

E. Kevin Hrusovsky
Quanterix Corporation - Chairman, President & CEO

Hey, Mark, it's great to be here. Thanks.

Questions & Answers

Mark Anthony Massaro
Canaccord Genuity Corp., Research Division - Senior Analyst

So you did report Q2 results yesterday. And it's interesting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot